Treatment of chronic hepatitis B infection: status quo and prospectWANG Jing-jing, CHEN Guo-feng, LIAO Jia-jie65-69,74
Treatment progress of chronic hepatitis C with direct-acting antivirals in special populationsLI Yuan-yuan, SHI Ji-jing, HUANG Lei, WANG Fu-Sheng70-74
Establishment and application of human liver chimeric mouse models in HBV-induced pathogenesisFU Zhong-xing, YANG Fan, WANG Ling, ZHANG Hong-wei, CAO Guang-wen75-81
Clinical trials progress of Ebola vaccinesWANG Yu-xiao, LI Jing-xin, WANG Yang, ZHU Wen-bo, ZHU Feng-cai82-85
Experiment of recombinant oncolytic influenza virus targecting effects on liver carcinoma cellsSUN Fang, REN Tian-yu, YAN Jin, DUAN Yue-qiang, WANG Xi-liang, ZHANG Shao-geng, YANG Peng-hui86-90,103
Ring-Box 1 gene negatively regulates anti-viral innate immune responseCHEN Xuan-nan, CHEN Qian-long, QUAN Shou-zhen91-94
Clinical characteristics and death risk factors of cirrhosis complicated with hepatorenal syndromeWANG Wen-ling, SU Xiao-feng, SU Mei, CHAO Hua, LIU Li-chang, WANG Ye95-98
Curative effect observation of 11 cases of primary liver cancer with obstructive jaundice treated by cyberknifeFAN Yu-ze, SUN Jing, LI Huan, SUN Ying-zhe, DUAN Xue-zhang99-103
An investigation of the intestinal outpatient service in 8 station hospitals in North ChinaZHAO Hong-mei, ZHANG Li, LI Huai-li, HU Bing-bing, CUI Shu-hua, GAO Rong, GAN Lu107-108,117